Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid

NCT03735537 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Osteogenesis Imperfecta

Interventions

DRUG: Teriparatide Pen Injector
DRUG: Zoledronic Acid

Sponsor

University of Edinburgh

Collaborators

[object Object]